Clinical ResearchBiomarkersTemporal Relationship and Predictive Value of Urinary Acute Kidney Injury Biomarkers After Pediatric Cardiopulmonary Bypass
Biomarkers
Under an Elsevier user license
open archive
Key Words
acute kidney injury
biomarkers
cardiopulmonary bypass
ischemia
Abbreviations and Acronyms
AKI
acute kidney injury
AUC
area under the curve
CPB
cardiopulmonary bypass
eCCl
estimated creatinine clearance
ELISA
enzyme-linked immunosorbent assay
IDI
integrated discrimination improvement
IL
interleukin
KIM
kidney injury molecule
L-FABP
liver fatty acid-binding protein
LOS
length of stay
NGAL
neutrophil gelatinase-associated lipocalin
NRI
net reclassification improvement
pRIFLE
pediatric modified Risk, Injury, Failure, Loss, and End-Stage Kidney Disease
RACHS-1
Risk Adjustment for Congenital Heart Surgery Score version 1
ROC
receiver-operating characteristic
SCr
serum creatinine
Cited by (0)
This study was supported by National Institutes of Health grants no. R01-HL08676, R01-HL085757, and R01-DK069749. Dr. Devarajan is a co-inventor on patents related to neutrophil gelatinase-associated lipocalin; is a consultant to Abbott Diagnostics and Biosite, Inc.; and is on the Speaker's Bureau of Abbott Diagnostics and Alere, Inc.
All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.